Lidocaine hydrochlori
Closed Solicitation Posted
- Solicitation number
- SPE2DP27T0191
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- More information
Notice details come from DLA DIBBS. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical (Medical Supply Chain) seeks quotes under request for quotation SPE2DP27T0191 for one package (line 0001, NSN 6505-01-386-7770) of Lidocaine Hydrochloride and Dextrose Injection USP, 2G (4 MG/ML), with quotes due November 3, 2026, a deadline that has passed as of today. The Set Aside line reads "No Set-Aside Used," and the procurement carries no set-aside restriction.
The solicitation is a Fast Auto Evaluation simplified acquisition issued by DLA office SPE2DP through DIBBS under the DLA Master Solicitation for Automated Simplified Acquisitions (Revision 105, May 20, 2026). Quotes must be submitted via DIBBS. Delivery is required within 5 days, FOB destination with inspection at destination, to Naval Med Readiness Logistics Command, Cheatham Annex, Williamsburg, Virginia. The item is 500 mL single-dose bags, 24 units per package, with a non-extendable 30-month shelf-life requirement (TYPE I CODE P item). The item is FDA-regulated and requires manufacturer confirmation via a product specialist referral in EBS. Specific approved manufacturers are listed as B. Braun Medical Inc (CAGE 11171), NDC 00264-9594-10, part number P5941. The solicitation incorporates DFARS Buy American and Balance of Payments Program requirements for quotes above the micro-purchase threshold, FAR 52.246-2 destination inspection, Medical Marking Standard No. 1 for packaging, and MIL-STD-2073-1E preservation and packing per special packaging instructions MPPWN00001 (Rev. 03/30/1988), with commercial packaging as specified. The PSC is 6505, Drugs and Biologicals.
The procurement history shows awards to vendor 0AG09 from 2017 through 2026 at unit costs of $169 to $283. Recent 2026 awards went to vendors 8H3Q8, 94J50, and 0ZSM5 at $272, $275, and $283, respectively.
Notice text
DLA request for quotation SPE2DP27T0191, issued by DLA office SPE2DP through DIBBS. Quotes are due by 11/03/2026. Set-aside: No Set-Aside Used. Solicitation type: Fast Auto Evaluation. FOB Destination. Inspection at Destination. Item: line 0001, LIDOCAINE HYDROCHLORI, NSN 6505-01-386-7770, 1 PG, delivery in 5 days, PR 7018885172. Quotes must be submitted via DIBBS.
Files
| File | Type | Posted |
|---|---|---|
| SPE2DP27T0191.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Lidocaine hydrochlo | Medical Supply Chain | No set-aside | |
| Lidocaine GEL | Medical Supply Chain | No set-aside | |
| Bupivacaine hydrochlo and 4 more items | Medical Supply Chain | No set-aside | |
| Bupivacaine and epine and 1 more item | Medical Supply Chain | No set-aside | |
| Bupivacaine and epine | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity